Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inogen Inc (INGN)

Inogen Inc (INGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 169,111
  • Shares Outstanding, K 27,232
  • Annual Sales, $ 348,670 K
  • Annual Income, $ -22,750 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.70
  • Price/Sales 0.49
  • Price/Cash Flow N/A
  • Price/Book 0.89

Options Overview Details

View History
  • Implied Volatility 97.91% (-0.45%)
  • Historical Volatility 41.63%
  • IV Percentile 66%
  • IV Rank 24.50%
  • IV High 254.91% on 03/13/26
  • IV Low 46.96% on 08/14/25
  • Expected Move (DTE 10) 1.20 (18.84%)
  • Put/Call Vol Ratio 0.30
  • Today's Volume 43
  • Volume Avg (30-Day) 55
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 638
  • Open Int (30-Day) 852
  • Expected Range 5.16 to 7.56

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.24
  • Number of Estimates 1
  • High Estimate $-0.24
  • Low Estimate $-0.24
  • Prior Year $-0.25
  • Growth Rate Est. (year over year) +4.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.86 +8.63%
on 03/31/26
6.66 -4.50%
on 03/26/26
-0.11 (-1.70%)
since 03/06/26
3-Month
5.34 +19.10%
on 02/25/26
7.46 -14.75%
on 01/07/26
-0.43 (-6.33%)
since 01/06/26
52-Week
5.34 +19.10%
on 02/25/26
9.13 -30.34%
on 10/22/25
-0.68 (-9.66%)
since 04/04/25

Most Recent Stories

More News
Inogen Announces the Appointment of Vafa Jamali to Board of Directors

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Vafa Jamali...

INGN : 6.36 (+2.42%)
Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Kevin Smith, President and...

INGN : 6.36 (+2.42%)
Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Compensation Committee...

INGN : 6.36 (+2.42%)
Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth

Jason Richardson Named Chief Financial Officer, Succeeding Michael Bourque Dominic Hulton Named Chief Marketing Officer Corey Moritz...

INGN : 6.36 (+2.42%)
Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Kevin Smith, President and...

INGN : 6.36 (+2.42%)
Inogen: Q4 Earnings Snapshot

Inogen: Q4 Earnings Snapshot

INGN : 6.36 (+2.42%)
Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook

Delivered full year revenue growth of approximately 4% Significantly improved profitability with 2025 net loss of $22.7 million and positive adjusted EBITDA of $2.7 million...

INGN : 6.36 (+2.42%)
Inogen Announces $30 Million Share Repurchase Program

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of Directors has...

INGN : 6.36 (+2.42%)
Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025

Inogen to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

INGN : 6.36 (+2.42%)
Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States

Expansion Aligns with Innovation and Growth Strategy

INGN : 6.36 (+2.42%)

Business Summary

Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen...

See More

Key Turning Points

3rd Resistance Point 6.87
2nd Resistance Point 6.68
1st Resistance Point 6.52
Last Price 6.36
1st Support Level 6.18
2nd Support Level 5.99
3rd Support Level 5.83

See More

52-Week High 9.13
Fibonacci 61.8% 7.68
Fibonacci 50% 7.24
Fibonacci 38.2% 6.79
Last Price 6.36
52-Week Low 5.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.